• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

芬兰旅行者分离出的肠炎沙门氏菌中氟喹诺酮敏感性降低。

Reduced fluoroquinolone susceptibility in Salmonella enterica isolates from travelers, Finland.

作者信息

Lindgren Marianne M, Kotilainen Pirkko, Huovinen Pentti, Hurme Saija, Lukinmaa Susanna, Webber Mark A, Piddock Laura J V, Siitonen Anja, Hakanen Antti J

机构信息

National Institute of Health and Welfare, Turku, Finland.

出版信息

Emerg Infect Dis. 2009 May;15(5):809-12. doi: 10.3201/eid1505.080849.

DOI:10.3201/eid1505.080849
PMID:19402977
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2687029/
Abstract

We tested the fluoroquinolone susceptibility of 499 Salmonella enterica isolates collected from travelers returning to Finland during 2003-2007. Among isolates from travelers to Thailand and Malaysia, reduced fluoroquinolone susceptibility decreased from 65% to 22% (p = 0.002). All isolates showing nonclassical quinolone resistance were from travelers to these 2 countries.

摘要

我们检测了2003年至2007年间从返回芬兰的旅行者中收集的499株肠炎沙门氏菌分离株对氟喹诺酮类药物的敏感性。在来自前往泰国和马来西亚旅行者的分离株中，氟喹诺酮类药物敏感性降低的情况从65%降至22%（p = 0.002）。所有表现出非典型喹诺酮耐药性的分离株均来自前往这两个国家的旅行者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c796/2687029/90d44e29014e/08-0849-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c796/2687029/972702c2fde4/08-0849-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c796/2687029/90d44e29014e/08-0849-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c796/2687029/972702c2fde4/08-0849-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c796/2687029/90d44e29014e/08-0849-F2.jpg

相似文献

1
Reduced fluoroquinolone susceptibility in Salmonella enterica isolates from travelers, Finland.芬兰旅行者分离出的肠炎沙门氏菌中氟喹诺酮敏感性降低。
Emerg Infect Dis. 2009 May;15(5):809-12. doi: 10.3201/eid1505.080849.
2
Reduced fluoroquinolone susceptibility in Salmonella enterica serotypes in travelers returning from Southeast Asia.从东南亚返回的旅行者中肠炎沙门氏菌血清型对氟喹诺酮类药物敏感性降低。
Emerg Infect Dis. 2001 Nov-Dec;7(6):996-1003. doi: 10.3201/eid0706.010613.
3
New quinolone resistance phenomenon in Salmonella enterica: nalidixic acid-susceptible isolates with reduced fluoroquinolone susceptibility.肠炎沙门氏菌中的新型喹诺酮耐药现象：对萘啶酸敏感但对氟喹诺酮敏感性降低的分离株
J Clin Microbiol. 2005 Nov;43(11):5775-8. doi: 10.1128/JCM.43.11.5775-5778.2005.
4
Contamination of chicken meat with Salmonella enterica Serovar Haardt with nalidixic acid resistance and reduced fluoroquinolone susceptibility.鸡肉被具有耐萘啶酸和降低的氟喹诺酮敏感性的肠炎沙门氏菌哈德尔血清型污染。
J Microbiol Biotechnol. 2008 Nov;18(11):1853-7. doi: 10.4014/jmb.0800.221.
5
Foreign travel and decreased ciprofloxacin susceptibility in Salmonella enterica infections.国外旅行与沙门氏菌感染中环丙沙星敏感性降低的关系。
Emerg Infect Dis. 2011 Jan;17(1):123-5. doi: 10.3201/eid1701.100999.
6
Increase in nalidixic acid resistance among non-Typhi Salmonella enterica isolates in the United States from 1996 to 2003.1996年至2003年美国非伤寒型肠炎沙门氏菌分离株中萘啶酸耐药性的增加。
Antimicrob Agents Chemother. 2007 Jan;51(1):195-7. doi: 10.1128/AAC.00222-06. Epub 2006 Nov 6.
7
In vitro activity of azithromycin against nontyphoidal Salmonella enterica.阿奇霉素对非伤寒沙门氏菌的体外活性。
Antimicrob Agents Chemother. 2010 Aug;54(8):3498-501. doi: 10.1128/AAC.01678-09. Epub 2010 May 24.
8
[Salmonella enterica with nonclassical quinolone resistance phenotype in pediatric patients].[小儿患者中具有非经典喹诺酮耐药表型的肠炎沙门氏菌]
Rev Esp Quimioter. 2015 Feb;28(1):36-8.
9
Trends in antimicrobial drug resistance in Salmonella enterica serotypes Typhi and Paratyphi A isolated in Europe, 1999-2001.1999 - 2001年欧洲分离的伤寒沙门氏菌血清型伤寒和甲型副伤寒的抗菌药物耐药性趋势
Int J Antimicrob Agents. 2003 Nov;22(5):487-91. doi: 10.1016/s0924-8579(03)00262-0.
10
Cefotaxime-resistant Salmonella enterica in travelers returning from Thailand to Finland.从泰国返回芬兰的旅行者中对头孢噻肟耐药的肠炎沙门氏菌
Emerg Infect Dis. 2014 Jul;20(7):1214-7. doi: 10.3201/eid2007.131744.

引用本文的文献

1
Travel-Related Antimicrobial Resistance: A Systematic Review.与旅行相关的抗菌药物耐药性：一项系统综述。
Trop Med Infect Dis. 2021 Jan 16;6(1):11. doi: 10.3390/tropicalmed6010011.
2
Antimicrobial investigation on the multi-state outbreak of salmonellosis and shigellosis in Iran.伊朗沙门氏菌病和志贺氏菌病多州暴发的抗菌药物调查。
Med J Islam Repub Iran. 2020 May 18;34:49. doi: 10.34171/mjiri.34.49. eCollection 2020.
3
First description of plasmid mediated quinolone resistance genes in salmonella isolates from Saudi hospitals.

本文引用的文献

1
Plasmid-mediated quinolone resistance in Salmonella enterica, United Kingdom.英国肠炎沙门氏菌中的质粒介导喹诺酮耐药性
Emerg Infect Dis. 2008 Feb;14(2):340-2. doi: 10.3201/eid1402.070573.
2
Antimicrobial drug resistance of Salmonella enterica serovar typhi in asia and molecular mechanism of reduced susceptibility to the fluoroquinolones.亚洲伤寒沙门氏菌肠炎血清型的抗菌药物耐药性及对氟喹诺酮类药物敏感性降低的分子机制。
Antimicrob Agents Chemother. 2007 Dec;51(12):4315-23. doi: 10.1128/AAC.00294-07. Epub 2007 Oct 1.
3
Plasmid-mediated quinolone resistance determinant qnrS1 detected in Salmonella enterica serovar Corvallis strains isolated in Denmark and Thailand.
沙特医院沙门氏菌分离株中质粒介导喹诺酮耐药基因的首次描述。
Saudi Med J. 2018 Jul;39(7):685-689. doi: 10.15537/smj.2018.7.22532.
4
Cefotaxime-resistant Salmonella enterica in travelers returning from Thailand to Finland.从泰国返回芬兰的旅行者中对头孢噻肟耐药的肠炎沙门氏菌
Emerg Infect Dis. 2014 Jul;20(7):1214-7. doi: 10.3201/eid2007.131744.
5
Revised Ciprofloxacin Breakpoints for Salmonella: Is it Time to Write an Obituary?沙门氏菌中修订后的环丙沙星断点：是时候写讣告了吗？
J Clin Diagn Res. 2013 Nov;7(11):2467-9. doi: 10.7860/JCDR/2013/7312.3581. Epub 2013 Nov 10.
6
In vitro synergism of ciprofloxacin and cefotaxime against nalidixic acid-resistant Salmonella enterica serotypes Paratyphi A and Paratyphi B.体外环丙沙星和头孢噻肟对萘啶酸耐药的伤寒血清型 A 和 B 的协同作用。
Antimicrob Agents Chemother. 2010 Sep;54(9):3696-701. doi: 10.1128/AAC.00988-09. Epub 2010 Jun 21.
7
In vitro activity of azithromycin against nontyphoidal Salmonella enterica.阿奇霉素对非伤寒沙门氏菌的体外活性。
Antimicrob Agents Chemother. 2010 Aug;54(8):3498-501. doi: 10.1128/AAC.01678-09. Epub 2010 May 24.
8
Travellers' diarrhoea - pros and cons of different prophylactic measures.旅行者腹泻——不同预防措施的利弊。
Wien Klin Wochenschr. 2009 Oct;121 Suppl 3:13-8. doi: 10.1007/s00508-009-1228-1.
9
Mechanisms of resistance in nontyphoidal Salmonella enterica strains exhibiting a nonclassical quinolone resistance phenotype.表现出非经典喹诺酮耐药表型的非伤寒肠炎沙门氏菌菌株的耐药机制。
Antimicrob Agents Chemother. 2009 Sep;53(9):3832-6. doi: 10.1128/AAC.00121-09. Epub 2009 Jul 13.
在丹麦和泰国分离出的肠炎沙门氏菌科瓦利斯菌株中检测到质粒介导的喹诺酮抗性决定因子qnrS1。
J Antimicrob Chemother. 2007 Sep;60(3):704-6. doi: 10.1093/jac/dkm261. Epub 2007 Jul 16.
4
Increase in nalidixic acid resistance among non-Typhi Salmonella enterica isolates in the United States from 1996 to 2003.1996年至2003年美国非伤寒型肠炎沙门氏菌分离株中萘啶酸耐药性的增加。
Antimicrob Agents Chemother. 2007 Jan;51(1):195-7. doi: 10.1128/AAC.00222-06. Epub 2006 Nov 6.
5
Genomic diversity within phage types of Salmonella enterica ssp. enterica serotypes Enteritidis and Typhimurium.肠炎沙门氏菌亚种肠炎血清型肠炎沙门氏菌和鼠伤寒沙门氏菌噬菌体类型内的基因组多样性。
Foodborne Pathog Dis. 2006 Spring;3(1):97-105. doi: 10.1089/fpd.2006.3.97.
6
Reduction in fluoroquinolone susceptibility among non-typhoidal strains of Salmonella enterica isolated from Finnish patients.从芬兰患者中分离出的肠炎沙门氏菌非伤寒菌株对氟喹诺酮类药物敏感性降低。
J Antimicrob Chemother. 2006 Mar;57(3):569-72. doi: 10.1093/jac/dkl002. Epub 2006 Jan 25.
7
New quinolone resistance phenomenon in Salmonella enterica: nalidixic acid-susceptible isolates with reduced fluoroquinolone susceptibility.肠炎沙门氏菌中的新型喹诺酮耐药现象：对萘啶酸敏感但对氟喹诺酮敏感性降低的分离株
J Clin Microbiol. 2005 Nov;43(11):5775-8. doi: 10.1128/JCM.43.11.5775-5778.2005.
8
Reduced fluoroquinolone susceptibility in Salmonella enterica serotypes in travelers returning from Southeast Asia.从东南亚返回的旅行者中肠炎沙门氏菌血清型对氟喹诺酮类药物敏感性降低。
Emerg Infect Dis. 2001 Nov-Dec;7(6):996-1003. doi: 10.3201/eid0706.010613.
9
An outbreak of multidrug-resistant, quinolone-resistant Salmonella enterica serotype typhimurium DT104.多重耐药、耐喹诺酮的肠炎沙门氏菌鼠伤寒血清型DT104暴发。
N Engl J Med. 1999 Nov 4;341(19):1420-5. doi: 10.1056/NEJM199911043411902.
10
Detection of decreased fluoroquinolone susceptibility in Salmonellas and validation of nalidixic acid screening test.沙门氏菌中氟喹诺酮敏感性降低的检测及萘啶酸筛选试验的验证
J Clin Microbiol. 1999 Nov;37(11):3572-7. doi: 10.1128/JCM.37.11.3572-3577.1999.